Fate Therapeutics
Price & Volume
Stats
See more52W Range | $0.66-$1.93 |
Market Cap | $170.7M |
Shares Short | 11M |
Financials
See moreRevenue (12 Mos) | $6.6M |
Revenue Growth (YoY) | -26.4% |
Gross Profit (12 Mos) | $6.6M |
Diluted EPS | -$1.33 |
News
See moreYahoo Finance • 13 days ago
IPSC-derived NK Cells Clinical Trial Pipeline Gains Momentum: 12+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
Yahoo Finance • 3 months ago
Fate Therapeutics to Present at Piper Sandler 37th Annual Healthcare Conference
Yahoo Finance • 4 months ago
Robert Bruce's Strategic Moves: AT&T Inc. Sees a -1.41% Portfolio Impact
Yahoo Finance • 4 months ago
Fate Therapeutics Reports Third Quarter 2025 Financial Results and Business Updates
About
CEO | Dr. Bahram Valamehr M.B.A., Ph.D. |
Address | 12278 Scripps Summit Drive, San Diego, CA, United States, 92131 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 181 |
